Evidence map›Paper›PMID 31855657›Full record

ArticleDrug and alcohol dependence2020

Injection drug use, unknown HIV positive status, and self-reported current PrEP use among Black men who have sex with men attending U.S. Black pride events, 2014-2017.

Jessica L Maksut, Rachel E Gicquelais, Kevon-Mark Jackman, Lisa A Eaton, M Revel Friedman, Derrick D Matthews, Leigh A Bukowski, Ron D Stall

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Missed Opportunity or Cause for Concern? Methamphetamine Use Is Associated With Greater Interest in Event-Driven PrEP Among Sexual Minority Men.AIDS education and prevention : official publication of the International Society for AIDS Education · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jessica L MaksutCenter for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA. Electronic address: jmaksut1@jhu.edu.
Rachel E GicquelaisCenter for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA.
Kevon-Mark JackmanCenter for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA.
Lisa A EatonCenter for Health, Intervention and Policy, University of Connecticut, Storrs Mansfield, CT USA.
M Revel FriedmanDepartment of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA USA.
Derrick D MatthewsDepartment of Health Behavior, University of North Carolina, Chapel Hill, NC USA.
Leigh A BukowskiDepartment of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA USA.
Ron D StallDepartment of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA USA.
Johns Hopkins University · USUniversity of Pittsburgh · USUniversity of Connecticut · USUniversity of North Carolina at Chapel Hill · US

Funding

Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Novel Stigma/Structural Interventions for Increasing HIV/STI Testing Among BMSMR01MH109409 · NIMH · UNIVERSITY OF CONNECTICUT STORRS · PI EATON, LISA A · 2016 to 2020
$3.7M
Understanding Delayed Access to HIV Prevention Services among Black MSMR01NR013865 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALBERT, STEVEN M · 2013 to 2017
$3.0M
Designing an Intervention to Increase Men's Linkage to Care and Prevention after HIV Self-Testing in UgandaK01MH115789 · NIMH · UNIVERSITY OF WASHINGTON · PI SHARMA, MONISHA · 2018 to 2022
$876k
Unified Approach to Address PrEP Cascade for BMSMR34MH115798 · NIMH · UNIVERSITY OF CONNECTICUT STORRS · PI EATON, LISA A · 2018 to 2020
$723k
NIAID NIH HHS T32 AI102623NIMH NIH HHS K01 MH115789NIMH NIH HHS R01 MH109409NIMH NIH HHS R34 MH115798NINR NIH HHS R01 NR013865
6 · The paper itself

Abstract

objectiveBlack gay, bisexual, and other men who have sex with men (BMSM) are at elevated risk for HIV infection in the United States. BMSM who inject drugs may be face even higher HIV risk.

methodsRandom time-location sampling was used to survey BMSM attending Black Pride events in 6 U.S. cities about HIV risk and protective behaviors, including injection drug use, prior HIV testing, and pre-exposure prophylaxis (PrEP). 3429 individuals who reported a HIV negative/unknown serostatus at enrollment were included in the analysis. HIV status was determined by in-field rapid HIV testing.

results3.6% of BMSM had injected drugs in their lifetime and 58.5% of BMSM who had injected drugs reported sharing syringes in the past six months. BMSM who had injected drugs more commonly reported current PrEP use than BMSM who had never injected (32.5% vs. 8.2%, p < 0.001). BMSM who had injected drugs were 3.6-fold (95% CI: 2.4, 5.4) more likely to report currently using PrEP than BMSM who had never injected after adjustment for sociodemographic, substance use, and sexual risk characteristics. Among BMSM who reported ever injecting drugs (n = 123), 31.7% tested HIV positive. HIV prevalence did not differ by self-reported PrEP use among BMSM who had injected drugs (p = 0.59).

conclusionsBMSM who inject drugs who reported currently using PrEP were no less likely to test positive for HIV than those who did not use PrEP. Wrap-around services to support consistent PrEP use and long-acting PrEP formulations may improve the effectiveness of PrEP among BMSM who inject drugs.

Indexed as

AdolescentAdultBlack or African AmericanCitiesHIV InfectionsHumansMaleNeedle SharingPre-Exposure ProphylaxisPrevalenceRisk FactorsSelf ReportSexual and Gender MinoritiesSexual BehaviorSubstance Abuse, IntravenousUnited StatesBlack men who have sex with men (MSM)MSM who inject drugsPre-Exposure prophylaxis (PrEP)

Identifiers

PMID31855657
PMCPMC7552112
OpenAlexW2996285144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.